• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    12/23/24 4:15:18 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email
    false 0001860543 0001860543 2024-12-20 2024-12-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    United States

    Securities and Exchange Commission

    Washington, D.C. 20549

     

    Form 8-K

    Current Report 

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): December 20, 2024

     

    CADRE HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware 001-40698 38-3873146
    (State or other jurisdiction (Commission File Number) (IRS Employer
    of incorporation)   Identification Number)

     

    13386 International Pkwy  
    Jacksonville, Florida 32218
    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (904) 741-5400

     

    N/A

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol Name of each exchange on which
    registered
    Common Stock, par value $.0001 CDRE New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

      x Emerging growth company

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

     

     

     

    Item 1.01 Entry into a Material Definitive Agreement.

     

    On December 20, 2024 (the “Closing Date”), Safariland, LLC, as borrower (the “Borrower”), a wholly owned subsidiary of Cadre Holdings, Inc. (the “Company”), the Company and certain domestic subsidiaries of the Company, as guarantors (the “Guarantors”), entered into an Amended and Restated Credit Agreement (the “A&R Credit Agreement”) with PNC Bank, National Association (“PNC”), as administrative agent, swingline loan lender and an issuing lender, and the several lenders party thereto (together with PNC, the “Lenders”) pursuant to which the existing Credit Agreement, dated as of July 23, 2021 (as amended prior to the Closing Date, the “Existing Credit Agreement”) by and among the Borrower, the Guarantors, the lenders from time to time party thereto and PNC, as administrative agent, swingline loan lender and an issuing lender, was amended and restated in its entirety.

     

    Pursuant to the A&R Credit Agreement, the Borrower may borrow up to (i) $175,000,000 under a revolving credit facility (including up to $30,000,000 for letters of credit and up to $10,000,000 for swing line loans) (the “Revolving Facility”), (ii) $225,000,000 under a term loan facility (the “Term Loans”), (iii) $115,000,000 under a delayed draw term loan a-1 facility that is available for drawing upon by the Borrower through June 20, 2025 (the “DDTL A-1 Facility”) and (iv) $75,000,000 under a delayed draw term loan a-2 facility that is available for drawing upon by the Borrower through June 20, 2026 (the “DDTL A-2 Facility”), each maturing on December 20, 2029, at which time the revolving commitments thereunder will terminate and all outstanding Revolving Loans, Term Loans and borrowings under the DDTL A-1 Facility and DDTL A-2 Facility, together with all accrued and unpaid interest thereon, must be repaid. No borrowings were made under the Revolving Facility, the DDTL A-1 Facility or the DDTL A-2 Facility on the Closing Date. The Amended and Restated Credit Agreement also permits the Borrower, subject to certain requirements set forth in the A&R Credit Agreement, to arrange with lenders for an aggregate of $100,000,000 (or more if certain leverage ratios are met) of additional revolving and/or term loan commitments (both of which are currently uncommitted).

     

    The proceeds of loans made under the Revolving Facility may be used for working capital and general corporate purposes, including capital expenditures, acquisitions and other investments permitted under the A&R Credit Agreement. The A&R Credit Agreement provides for certain conditions precedent to be satisfied for any borrowings to be made under the DDTL A-1 Facility and the DDTL A-2 Facility. Subject to fulfilling such conditions, the DDTL A-1 Facility may be drawn upon in up to two draws by the Borrower through and including June 20, 2025, and the DDTL A-2 Facility may be drawn upon in one or more draws by the Borrower through and including June 20, 2026. The proceeds of loans made under the DDTL A-1 Facility may be used only for certain permitted acquisitions under the A&R Credit Agreement, as more fully set forth in, and subject to the conditions of, the A&R Credit Agreement, as well as to pay fees and expenses incurred in connection therewith. The proceeds of loans made under the DDTL A-2 Facility may be used for general corporate purposes, including to finance other permitted acquisitions under the A&R Credit Agreement, as more fully set forth therein.

     

    The Term Loans were fully drawn on the Closing Date and cannot be reborrowed. The proceeds of the Term Loans were used to refinance in full the outstanding term loans under the Existing Credit Agreement and to pay fees and expenses incurred in connection with entering into the A&R Credit Agreement and the making of the Term Loans. Commencing March 31, 2025, the Term Loans require scheduled quarterly payments in amounts equal to 1.25% per quarter of the original aggregate principal amount of the Term Loans, with the balance due at maturity.

     

    The A&R Credit Agreement is guaranteed, jointly and severally, by the Guarantors and, subject to certain exceptions, secured by a first-priority security interest in substantially all of the assets of the Borrower and the Guarantors  pursuant to an Amended and Restated Security and Pledge Agreement and an Amended and Restated Guaranty and Suretyship Agreement, each dated as of the Closing Date.

     

     

     

     

    The Borrower may elect to have the loans under the A&R Credit Agreement bear interest at a base rate or a term SOFR rate, in each case, plus an applicable margin. The applicable margin will range from 0.50% to 1.50% per annum, in the case of base rate borrowings, and 1.50% to 2.50% per annum, in the case of term SOFR rate borrowings, based upon the Company’s consolidated total net leverage ratio as more fully set forth in the A&R Credit Agreement. The A&R Credit Agreement also requires the Borrower to pay a commitment fee on the unused portion of the loan commitments under the Revolving Facility, the DDTL A-1 Facility and the DDTL A-2 Facility. Such commitment fee will range between 0.175% and 0.25% per annum, and is also based upon the Company’s consolidated total net leverage ratio as more fully set forth in the A&R Credit Agreement. The Company is also obligated to pay other customary closing fees, arrangement fees, administration fees and letter of credit fees for a credit facility of this size and type.

     

    The A&R Credit Agreement contains customary representations and warranties, and affirmative and negative covenants, including limitations on additional indebtedness, dividends, and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens on the assets of the Borrowers or any Guarantor, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions, dispositions, and mandatory prepayments in connection with certain liquidity events.

     

    The A&R Credit Agreement contains customary events of default that include, among others, non-payment of principal, interest or fees, violation of covenants, inaccuracy of representations and warranties, failure to make payment on, or defaults with respect to, certain other material indebtedness, bankruptcy and insolvency events, material judgments and change of control provisions. Upon the occurrence of an event of default, and after the expiration of any applicable grace period, payment of any outstanding loans under the A&R Credit Agreement may be accelerated and the Lenders could foreclose on their security interests in the assets of the Borrowers and the Guarantors.

     

    Certain of the lenders under the A&R Credit Agreement and their affiliates have engaged in, and may in the future engage in, investment banking, commercial lending and other commercial dealings in the ordinary course of business with the Company or the Company’s affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions.

     

    The foregoing description of the A&R Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the A&R Credit Agreement, a copy of which is filed herewith as Exhibit 10.1 and is incorporated herein by reference.

     

    Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

     

    The information set forth under Item 1.01 of this Current Report on Form 8-K is hereby incorporated in this Item 2.03 by reference.

     

    Item 9.01    Financial Statements and Exhibits

     

    (d)       Exhibits. The following Exhibit is filed herewith as a part of this Current Report on Form 8-K:

     

    Exhibit Description
       
    10.1 Amended and Restated Credit Agreement, dated as of December 20, 2024, by and among, Safariland, LLC, the Guarantors party thereto, the Lenders party thereto and PNC Bank, National Association, as Administrative Agent, Swingline Loan Lender and an Issuing Lender.
       
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: December 23, 2024

     

      CADRE HOLDINGS, INC.
         
      By: /s/ Blaine Browers
      Name: Blaine Browers
      Title: Chief Financial Officer

     

     

     

    Get the next $CDRE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    8/13/2025$26.00Neutral → Underperform
    BofA Securities
    6/13/2025$38.00Buy → Neutral
    BofA Securities
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    More analyst ratings

    $CDRE
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Cadre Holdings Inc.

    SCHEDULE 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/26 4:13:47 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

    SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/5/26 1:20:38 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Amendment: Cadre Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K/A - Cadre Holdings, Inc. (0001860543) (Filer)

    2/2/26 8:30:46 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Neutral to Underperform and set a new price target of $26.00

    8/13/25 8:01:40 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Buy to Neutral and set a new price target of $38.00

    6/13/25 7:45:51 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ROTH MKM reiterated coverage on Cadre Holdings with a new price target

    ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

    2/21/24 9:51:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Cadre Holdings Completes Acquisition of TYR Tactical

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, has completed the Company's previously announced acquisition of TYR Tactical, LLC, a leading global manufacturer of tactical gear and equipment for military, law enforcement, and government agencies worldwide. The purchase price consisted of $120.0 million of cash and $24.0 million of Cadre common stock, as well as $1.0 million of Cadre common stock in the form of restricted stock unit awards to be granted to certain employees of TYR Tactical1. In addition, t

    2/2/26 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Increases Dividend

    Declares Quarterly Dividend of $0.10 Per Share; ~5% Increase on Annualized Basis Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share, or $0.40 per share on an annualized basis, on the Company's common stock. On an annualized basis, the newly declared cash dividend represents an increase of 2 cents, or approximately 5%, over the previous annualized dividend of $0.38 per share. Cadre's dividend payment will be m

    1/20/26 4:42:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Participate in CJS Securities 26th Annual New Ideas for the New Year Conference

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that Brad Williams, President, and Blaine Browers, Chief Financial Officer, are scheduled to present at the CJS Securities 26th Annual New Ideas for the New Year Conference on Wednesday, January 14, 2026 at 10:15 a.m. ET. Cadre management will also participate in investor meetings held in conjunction with the conference. The presentation will be available via a live listen-only webcast and can be accessed through the Investor Relations section

    1/6/26 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B gifted 12,250 shares (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    12/29/25 4:15:16 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CHIEF FINANCIAL OFFICER Browers Blaine sold $894,849 worth of shares (20,435 units at $43.79), decreasing direct ownership by 24% to 63,142 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    12/16/25 4:15:25 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    PRESIDENT Williams Brad sold $1,031,760 worth of shares (24,000 units at $42.99), decreasing direct ownership by 30% to 54,719 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    12/12/25 4:15:36 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    11/12/24 9:50:14 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/24 7:58:49 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/24 4:15:31 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Financials

    Live finance-specific insights

    View All

    Cadre Holdings Increases Dividend

    Declares Quarterly Dividend of $0.10 Per Share; ~5% Increase on Annualized Basis Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share, or $0.40 per share on an annualized basis, on the Company's common stock. On an annualized basis, the newly declared cash dividend represents an increase of 2 cents, or approximately 5%, over the previous annualized dividend of $0.38 per share. Cadre's dividend payment will be m

    1/20/26 4:42:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Reports Third Quarter 2025 Financial Results

    Grew Quarterly Net Sales 42% and Gross Profit 66% Year-Over-Year Increased Quarterly Adjusted EBITDA of $29.8 Million and Expanded Adjusted EBITDA Margin of 19.1% Organic Backlog Increased $20 Million from Q2 to Q3 Med-Eng Awarded $50 Million IDIQ with DoD – First PO issued for $10 Million to be Shipped in 2026 Agrees to Acquire TYR Tactical, Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results f

    11/4/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings to Acquire TYR Tactical

    Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields to Tactical Teams Expected to be Immediately Accretive and Advances Strategic Focus on Mission-Critical Products with High Margins, Strong Cash Flows Provides Significant Entry into New Markets, Particularly in European Military and Defense Management Will Host a Conference Call at 10 a.m. ET to Discuss the Transaction Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today it has entered into a definitive agreement to acquire

    10/29/25 6:00:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    View All

    Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

    1/13/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

    4/12/22 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

    VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

    4/7/22 8:05:00 AM ET
    $CDRE
    $SOLO
    Industrial Specialties
    Health Care
    Auto Manufacturing
    Consumer Discretionary